Issue 5/2007
Content (15 Articles)
WP760, a melanoma selective drug
Mingzhong Zheng, Waldemar Priebe, Eugene T. Walch, Katherine G. Roth, Mikyung Han, Chi-Hui Tang, Sangkyou Lee, Nancy J. Poindexter, Izabela Fokt, Elizabeth A. Grimm
Novel paclitaxel formulations for oral application: a phase I pharmacokinetic study in patients with solid tumours
S. A. Veltkamp, H. Rosing, A. D. R. Huitema, M. R. Fetell, A. Nol, J. H. Beijnen, J. H. M. Schellens
Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model
Sarah Brem, Betty Tyler, Khan Li, Gustavo Pradilla, Federico Legnani, Justin Caplan, Henry Brem
Short hairpin RNAs targeting Bcl-xL modulate senescence and apoptosis following SN-38 and irinotecan exposure in a colon cancer model
S. M. Guichard, M. L. Hua, P. Kang, J. S. Macpherson, D. I. Jodrell
Phase I study of gefitinib, irinotecan, 5-fluorouracil and leucovorin in patients with metastatic colorectal cancer
Jeffrey A. Meyerhardt, Jeffrey W. Clark, Jeffrey G. Supko, Joseph P. Eder, Shuji Ogino, Clinton F. Stewart, Ferdinando D’Amato, Janet Dancey, Peter C. Enzinger, Andrew X. Zhu, David P. Ryan, Craig C. Earle, Robert J. Mayer, Ann Michelini, Kate Kinsella, Charles S. Fuchs
Comparison between sonodynamic effect with protoporphyrin IX and hematoporphyrin on sarcoma 180
QuanHong Liu, XiaoBing Wang, Pan Wang, LiNa Xiao, Qiao Hao
Vaticanol C, a novel resveratrol tetramer, reduces lymph node and lung metastases of mouse mammary carcinoma carrying p53 mutation
Masa-Aki Shibata, Yukihiro Akao, Eiko Shibata, Yoshinori Nozawa, Tetsuro Ito, Satoshi Mishima, Junji Morimoto, Yoshinori Otsuki
Effect of gastrectomy on the pharmacokinetics of S-1, an oral fluoropyrimidine, in resectable gastric cancer patients
Mitsugu Kochi, Masashi Fujii, Noriaki Kanamori, Teruo Kaiga, Kazuo Aizaki, Toru Takahashi, Tadatoshi Takayama
Synergistic interaction between tetrandrine and chemotherapeutic agents and influence of tetrandrine on chemotherapeutic agent-associated genes in human gastric cancer cell lines
Jia Wei, Baorui Liu, Lifeng Wang, Xiaoping Qian, Yitao Ding, Lixia Yu
Role of NADPH cytochrome P450 reductase in activation of RH1
Asher Begleiter, Marsha K. Leith, Daywin Patel, Brian B. Hasinoff
Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer: a lung cancer Galician group phase II study
Joaquín Casal, Margarita Amenedo, José Ramón Mel, Luis Miguel Antón, Rubén Rodríguez-López, Rafael López-López, Ana González-Ageitos, Javier Castellanos, Manuel Constenla, José L. Tisaire
Weekday on-weekend off oral capecitabine: a phase I study of a continuous schedule better simulating protracted fluoropyrimidine therapy
G. Pentheroudakis, P. Pappas, V. Golfinopoulos, G. Fountzilas, M. Nikolaidou, V. A. Boumba, T. Vougiouklakis, L. Nikiforidis, E. Tzamakou, O. Siarabi, M. Marselos, N. Pavlidis
Tetrandrine achieved plasma concentrations capable of reversing MDR in vitro and had no apparent effect on doxorubicin pharmacokinetics in mice
Chun-Ling Dai, Hui-Yu Xiong, Li-Fen Tang, Xu Zhang, Yong-Ju Liang, Mu-Sheng Zeng, Li-Ming Chen, Xiao-Hong Wang, Li-Wu Fu
The inhibition of glutamine synthetase sensitizes human sarcoma cells to l-asparaginase
S. Tardito, J. Uggeri, C. Bozzetti, M. G. Bianchi, B. M. Rotoli, R. Franchi-Gazzola, G. C. Gazzola, R. Gatti, O. Bussolati
Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (Abraxane®) on three treatment schedules in patients with solid tumors
Thomas E. Stinchcombe, Mark A. Socinski, Christine M. Walko, Bert H. O’Neil, Frances A. Collichio, Anastasia Ivanova, Hua Mu, Michael J. Hawkins, Richard M. Goldberg, Celeste Lindley, E. Claire Dees